No Data
No Data
Insider Sale: Chief Med and Dev Officer of $CRNX Sells 127 Shares
Express News | Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
We Think Crinetics Pharmaceuticals (NASDAQ:CRNX) Can Afford To Drive Business Growth
Morgan Stanley Initiates Crinetics(CRNX.US) With Buy Rating, Announces Target Price $70
Crinetics Pharma's Earnings Call: Progress Amid Challenges